These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2260089)

  • 1. Immunosuppression by aldicarb of T cell responses to antigen-specific and polyclonal stimuli results from defective IL-1 production by the macrophages.
    Dean TN; Kakkanaiah VN; Nagarkatti M; Nagarkatti PS
    Toxicol Appl Pharmacol; 1990 Dec; 106(3):408-17. PubMed ID: 2260089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldicarb treatment inhibits the stimulatory activity of macrophages without affecting the T-cell responses in the syngeneic mixed lymphocyte reaction.
    Dean TN; Selvan RS; Misra HP; Nagarkatti M; Nagarkatti PS
    Int J Immunopharmacol; 1990; 12(3):337-48. PubMed ID: 2139433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 increases IL-2 production by T cells in response to accessory cell-independent stimuli.
    Tanaka T; Ben-Sasson SZ; Paul WE
    J Immunol; 1991 Jun; 146(11):3831-9. PubMed ID: 1827817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methyl substitutions on benz[a]anthracene derivatives-induced immunosuppression.
    Saas P; Bohuon C; Pallardy M
    J Toxicol Environ Health; 1996 Nov; 49(4):371-87. PubMed ID: 8931739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: II. The role of the T-lymphocyte.
    Dooley RK; Morris DL; Holsapple MP
    Immunopharmacology; 1990; 19(1):47-58. PubMed ID: 2307581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro T cell unresponsiveness following low-dose injection of anti-CD3 MoAb.
    Ben-Amor A; Leite-De-Moraes MC; Lepault F; Schneider E; Machavoine F; Arnould A; Chatenoud L; DY M
    Clin Exp Immunol; 1996 Mar; 103(3):491-8. PubMed ID: 8608651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mitogen-induced expression of high-affinity interleukin 2 receptors on spleen cells from NOD/Shi/Kbe mice.
    Hatamori N; Yokono K; Nagata M; Shii K; Baba S
    Diabetes; 1990 Sep; 39(9):1070-8. PubMed ID: 2384189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin enhances T cell function by modulating interleukin activities.
    Stünkel KG; Hewlett G; Zeiler HJ
    Clin Exp Immunol; 1991 Dec; 86(3):525-31. PubMed ID: 1836163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran (SPG).
    Tsuchiya Y; Igarashi M; Inoue M; Kumagai K
    J Pharmacobiodyn; 1989 Oct; 12(10):616-25. PubMed ID: 2534316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine lymphocytes exhibit heterogeneity in their proliferative responsiveness to calcium ionophore.
    Kakkanaiah VN; Nagarkatti PS; Nagarkatti M
    Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):533-43. PubMed ID: 1483106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of interleukin 1 alpha mRNA during the antigen-dependent interaction of sensitized T lymphoblasts with macrophages.
    Koide S; Steinman RM
    J Exp Med; 1988 Jul; 168(1):409-16. PubMed ID: 2969406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes.
    Saron MF; Shidani B; Nahori MA; Guillon JC; Truffa-Bachi P
    J Virol; 1990 Sep; 64(9):4076-83. PubMed ID: 2143539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective antigen presentation to a cloned T helper cell by macrophages from burned mice can be restored with interleukin-1.
    Kupper TS; Green DR; Durum SK; Baker CC
    Surgery; 1985 Aug; 98(2):199-206. PubMed ID: 3161195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium periodate-induced T cell mitogenesis: an analysis of the requirement for Ia and IL 1.
    Smith LA; Cohen DA; Lachman LB; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1137-44. PubMed ID: 2989361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
    Akarid K; Pocidalo MA; Desforges B; Sinet M
    Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of murine interleukin 1: stimuli and responsive primary cells.
    Koide S; Steinman RM
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3802-6. PubMed ID: 3495797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced proliferation of murine T cell lines following interaction of poly(Glu60,Phe40) (GPhe) and antigen-presenting accessory cells. II. The role of accessory cells and cytokines in the activity of GPhe on antigen-independent proliferation.
    Grun JL; Liu DC; Maurer PH
    Cell Immunol; 1990 Aug; 129(1):213-27. PubMed ID: 1694731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age- and strain-related differences in murine spleen cell responses to different activation signals.
    Kariv I; Ferguson FG; Confer FL
    Cell Immunol; 1992 Mar; 140(1):67-80. PubMed ID: 1531455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
    Vercammen C; Ceuppens JL
    Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.